crispr-mediated direct mutation cancer genes mouse liver 
study cancer genes mouse models traditionally relied genetically-engineered strains made via transgenesis gene targeting embryonic stem cells1 describe new method cancer model generation using crispr/cas clustered regularly interspaced short palindromic repeats/crispr-associated proteins system vivo wild-type mice used hydrodynamic injection deliver crispr plasmid dna expressing cas9 single guide rnas sgrnas2- liver directly target tumour suppressor genes pten ref p53 also known tp53 trp53 ref alone combination crispr-mediated pten mutation led elevated akt phosphorylation lipid accumulation hepatocytes phenocopying effects deletion gene using cre-loxp technology78 simultaneous targeting pten p53 induced liver tumours mimicked caused cre-loxp-mediated deletion pten p53 dna sequencing liver tumour tissue revealed insertion deletion mutations tumour suppressor genes including bi-allelic mutations pten p53 tumours furthermore co-injection cas9 plasmids harbouring sgrnas targeting beta-catenin gene single-stranded dna oligonucleotide donor carrying activating point mutations led generation hepatocytes nuclear localization b-catenin study demonstrates feasibility direct mutation tumour suppressor genes oncogenes liver using crispr/cas system presents new avenue rapid development liver cancer models functional genomics 
